MedPath

Evaluation of surrogate markers of protection for the evaluation of vaccine strategies against mycobacterial infections in BCG-revaccinated individuals

Not Applicable
Conditions
Tuberculosis
C01.252.410.040.552.846
Registration Number
RBR-2gv984
Lead Sponsor
Fundação Oswaldo Cruz - Bahia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Healthy volunteers; enrolled in the first year of graduate courses of Medicine, Physiotherapy, Dentistry, Nursing, Phonoaudiology, Nutrition or Pharmacy of two universities; with visible/measurable BCG scar; negative in double testing with PPD RT 23 (2 tuberculin units, 7-10 days of interval between tests).

Exclusion Criteria

Positive serology for the human immunodifciency virus (HIV 1/2) using an immunoenzimatic assay (ELISA); HIV test refusal.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath